Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LARD: Switch to Atazanavir/r or Darunavir/r for HIV-related Hypertriglyceridemia
NCT00756730Phase 4Completed
- Sponsor
- Community Research Initiative of New England
- Start
- Sep 2008
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of darunavir in human immunodeficiency virus infection (HIV), hypertriglyceridemia, sponsored by Community Research Initiative of New England. Started Sep 2008; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus infection (HIV)hypertriglyceridemia
Beyond the preview
Go deeper on NCT00756730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00756730.